Second-generation HIV microbicides: continued development of griffithsin.
Mapp Biopharmaceutical, Inc., 6160 Lusk Boulevard, C105, San Diego, CA 92121, USA. larry.zeitlin@mappbio.com
Larry
L
Zeitlin
Michael
M
Pauly
Kevin J
KJ
Whaley
D020418:Algal Proteins / Q000494:pharmacology*; D000818:Animals; D015195:Drug Design; D005260:Female; D023581:HIV Fusion Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D008297:Male; D037121:Plant Lectins; D011485:Protein Binding / Q000187:drug effects
D020418:Algal Proteins; D023581:HIV Fusion Inhibitors; D037102:Lectins; D037121:Plant Lectins; C499654:griffithsin protein, Griffithsia